GENZ Biotechnology bunu yeniden yayınladı
In Vitro Diagnostics Market Size to reach $119.4 billion by 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 https://lnkd.in/dzdfS43f The global in vitro diagnostics market in terms of revenue was estimated to be worth $85.2 billion in 2024 and is poised to reach $119.4 billion by 2029, growing at a CAGR of 6.9% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Siemens Healthineers AG (Germany), and Thermo Fisher Scientific 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲: Fapon 开立医疗 SonoScape APIFARMA - Portuguese Pharmaceutical Industry Association Invisible Sentinel, Inc. Vazyme Biotech Roche Canada Eurogentec MicroBio Consulting AXEME AliveDx Congenica Johari Digital Healthcare Limited MedTech Mavens LLC Mindray Europe ELITechGroup Fujifilm Healthcare UK MDC Associates, Inc. Medix Biochemica Qserve Group Diatron Medical Instruments SD BIOSENSOR INC J Mitra & Co Pvt Ltd Fujirebio Europe STRATEC SE AB ANALITICA GENZ Biotechnology Aidian Insignia Clinical Services CARLO ERBA Reagents (DASIT Group) Abionic Mindray Indonesia ArcticZymes Technologies ASA Economist Intelligence: Clearstate Quest Diagnostics BioPharma Services Evnia @@CAPEBIO 1MED SA Medcaptain Zimmer and Peacock Ltd Real Regulatory Ltd